Analyst
Oppenheimer
Equibles does not estimate personal net worth.
Leland Grishel is recorded as Analyst at Oppenheimer. Leland Grishel has spoken on 3 investor events across 3 companies, most recently for Veru Inc. on February 26, 2026. Those appearances were for Veru Inc. (VERU), Turn Therapeutics Inc. (TTRX) and SAB Biotherapeutics, Inc. (SABS). The companies whose calls Leland Grishel spoke on are classified in the Healthcare sector.
“Thank you, and thanks for joining us here at Oppenheimer's 36th Annual Healthcare Life Sciences Conference. I'm Leland Grishel, one of the analysts with the biotech equity research team at the firm, and we're delighted to have with us as our next presenting company, Veru, which is a public company.”
“Welcome to our first session here at Oppenheimer's 36th Annual Healthcare Life Sciences Conference. I'm Leland Grishel, one of the biotech analysts with the team.”
“Thank you, and welcome, everyone, to our next presenting company here at Oppenheimer's 36th Annual Healthcare Life Sciences Conference.”
Oppenheimer
Analyst
Transcript header (unverified)
VERU
Biotechnology · Healthcare
